Risk Adjusted Returns Analysis |
| Investment horizon: | 30 Days Login to change |
| Make sure to specify reasonable number of assets as computing power is limited. |
Analyze Watchlist
|
| Hypothetical Portfolio |
|
|
| Amount | Current Allocation | |||||
ABT
|
754 | 8.30 % |
|
|||
JNJ
|
1,772 | 19.50 % |
|
|||
AZN
|
1,034 | 11.38 % |
|
|||
MRK
|
947 | 10.42 % |
|
|||
LLY
|
1,103 | 12.14 % |
|
|||
BMY
|
881 | 9.70 % |
|
|||
SNY
|
1,101 | 12.12 % |
|
|||
NVS
|
1,493 | 16.43 % |
|
|
| Efficiency (Sharpe Ratio) | Risk (Volatility) | Expected Return | Current Price | Advice * | ||
| Johnson Johnson | 0.22% | 0.76% | 0.18% | 88.59 | ||
| BristolMyers Squibb Company | 0.12% | 1.82% | 0.22% | 44.06 | ||
| Novartis AG | 0.11% | 0.83% | 0.10% | 74.63 | ||
| Abbott Laboratories | 0.09% | 1.31% | 0.13% | 37.72 | ||
| Sanofi | 0.06% | 1.90% | 0.12% | 55.05 | ||
| AstraZeneca PLC | 0.02% | 0.69% | 0.02% | 51.71 | ||
| Eli Lilly and Company | 0.16% | 1.38% | 0.21% | 55.14 | ||
| Merck Co Inc | 0.25% | 1.13% | 0.27% | 47.33 |
Technical analysis of total daily returns
|